<--- Back to Details
First PageDocument Content
Medicine / Yellow Card Scheme / Adverse effect / Suspected Adverse Reaction Surveillance Scheme / Hoddesdon / Commission on Human Medicines / Merck & Co. / MSD / Patient information leaflet / Pharmacology / Pharmaceutical sciences / Health
Date: 2014-10-14 07:41:06
Medicine
Yellow Card Scheme
Adverse effect
Suspected Adverse Reaction Surveillance Scheme
Hoddesdon
Commission on Human Medicines
Merck & Co.
MSD
Patient information leaflet
Pharmacology
Pharmaceutical sciences
Health

MSD Hertford Road Hoddesdon Hertfordshire EN11 9BU UK Telephone +[removed]467272

Add to Reading List

Source URL: www.mhra.gov.uk

Download Document from Source Website

File Size: 173,75 KB

Share Document on Facebook

Similar Documents

DEVELOPMENT OF PHARMACEUTICAL PRODUCTS UTILIZING EXTRUSION TECHNOLOGIES  Graciela Terife Senior Scientist,  Product Value Enhancement Merck & Co., Summit, NJ

DEVELOPMENT OF PHARMACEUTICAL PRODUCTS UTILIZING EXTRUSION TECHNOLOGIES Graciela Terife Senior Scientist, Product Value Enhancement Merck & Co., Summit, NJ

DocID: 1nXt9 - View Document

Title: font: times; size: 18 point; style: plain; justified: center; capitalization: first word and Names only THE CHALLENGE OF DEVELOPING AN MMR­VVV COMBINATION VACCINE Alan R. Shaw, PhD

Title: font: times; size: 18 point; style: plain; justified: center; capitalization: first word and Names only THE CHALLENGE OF DEVELOPING AN MMR­VVV COMBINATION VACCINE Alan R. Shaw, PhD

DocID: 1gGkP - View Document

Your contact  News Release Gangolf Schrimpf

Your contact News Release Gangolf Schrimpf

DocID: 1aWSz - View Document

TRUSOPT Ped data PAR

TRUSOPT Ped data PAR

DocID: 1aNXe - View Document

CNODES: A Canadian Initiative Samy Suissa Lady Davis Institute, Jewish General Hospital McGill University Montreal, Canada

CNODES: A Canadian Initiative Samy Suissa Lady Davis Institute, Jewish General Hospital McGill University Montreal, Canada

DocID: 1aAtH - View Document